PharmaBoardroom

Mark Lotter – Founder & CEO, Nuance Biotech, China

Mark Lotter, founder and CEO of Nuance Biotech, explains why he decided to return to the China market to establish Nuance Biotech, two years after his…

Michael Zhang – Chairman, Peijia Medical, China

Michael Zhang, chairman of Peijia Medical, shares Peijia Medical’s mission to become a two-platform medical device company as well as the partner of…

The Youngest Ever Czech Health Minister’s Ambitious Reform…

The Czech Republic's Minister of Health, Adam Vojtěch, is the youngest in the country's history and has set out an ambitious reform programme to…

Mátyás Szentiványi – Director General, National…

Dr Mátyás Szentiványi, Director General of the National Institute of Pharmacy and Nutrition (OGYEI), introduces the administrative authority and…

Maryam Matar – Founder and Chairperson, United Arab…

The United Arab Emirates Genetic Diseases Association (UAEGDA) was established in 2006 and aims to increase awareness programs in order to prevent the…

Martin Mátl – Executive Director, ČAFF, Czech Republic

Martin Mátl, executive director of the Czech Association of Pharmaceutical Companies (ČAFF), shares the key priorities and challenges of the…

Recent Big-Ticket Investments in Hungarian Pharma

Hungarian national champion Egis and French Big Pharma Sanofi have both made recent big-ticket investments in new facilities in Hungary. Egis' new…

GSK CEO Emma Walmsley In Conversation

In conversation at the FT Global Pharmaceutical and Biotechnology Conference in London,* an energetic Emma Walmsley discussed the strategic and…

Ana Raposo – Country Director Gulf Countries, Janssen

Ana Raposo, country director for Gulf Countries at Janssen discusses her role, the main similarities and differences between the various markets…

China’s MAH System and Bringing New Drugs to Market

China's new Amended Drug Administration Law is being enacted to strengthen and streamline its regulation of the pharmaceutical industry. The amended…

China Cracks Down on Counterfeit and Substandard Drugs

China’s new Amended Drug Administration Law is being enacted to strengthen and streamline its regulation of the pharmaceutical industry as well as…

Regulatory Reforms: United Kingdom

Want to know more about regulatory reforms in United Kingdom? Read on! Prepared in association with Clyde & Co, a leading law firm in United…

Tagged with EG